Literature DB >> 4392015

Polymyalgia rheumatica.

G G Hunder, T F Disney, L E Ward.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 4392015

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  13 in total

1.  Circulating immunoblasts in polymyalgia rheumatica.

Authors:  A A Eghtedari; W Esselinckx; P A Bacon
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

Review 2.  Giant cell arteritis in general practice.

Authors:  D J Rhodes
Journal:  J R Coll Gen Pract       Date:  1976-05

3.  Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.

Authors:  R G Grau; S S Kassan; J J Franks; H Kaplan; S H Walker; E M Tan
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

4.  Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica.

Authors:  B L Hazleman; I C Maclennan; M M Esiri
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

5.  Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8.

Authors:  B Hazleman; A Goldstone; D Voak
Journal:  Br Med J       Date:  1977-10-15

6.  Laboratory tests in the rheumatic disease.

Authors:  S L Aaron
Journal:  Can Fam Physician       Date:  1988-02       Impact factor: 3.275

7.  Passive ocular proptosis.

Authors:  B P O'Neill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

8.  Immunological and histological study of temporal arteries.

Authors:  J R Park; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

Review 9.  Giant cell arteritis (cranial arteritis, polymyalgia rheumatica).

Authors:  M Mumenthaler
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

Review 10.  Controversies regarding giant cell (temporal, cranial) arteritis.

Authors:  J Eshaghian
Journal:  Doc Ophthalmol       Date:  1979-09-17       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.